Drägerwerk AG & Co. KGaA
Drägerwerk AG & Co. KGaA (DGWPF) Financial Performance & Income Statement Overview
Review Drägerwerk AG & Co. KGaA (DGWPF) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Drägerwerk AG & Co. KGaA (DGWPF) Income Statement & Financial Overview
Access detailed annual and quarterly income data for Drägerwerk AG & Co. KGaA DGWPF financial performance.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $730.26M | $1.08B | $774.57M | $784.67M |
| Cost of Revenue | $395.66M | $581.84M | $437.62M | $436.79M |
| Gross Profit | $334.60M | $493.98M | $336.95M | $347.89M |
| Gross Profit Ratio | $0.46 | $0.46 | $0.44 | $0.44 |
| R&D Expenses | $83.56M | $82.77M | $85.77M | $83.61M |
| SG&A Expenses | $249.74M | $287.15M | $236.42M | $246.91M |
| Operating Expenses | $332.93M | $394.69M | $312.94M | $307.38M |
| Total Costs & Expenses | $728.59M | $976.52M | $750.56M | $767.30M |
| Interest Income | $2.07M | $0.00 | $0.00 | $1.16M |
| Interest Expense | $5.35M | $0.00 | $3.28M | $5.10M |
| Depreciation & Amortization | $32.92M | $48.65M | $32.97M | $32.53M |
| EBITDA | $2.48M | $121.73M | $24.008M | $73.78M |
| EBITDA Ratio | $0.003 | $0.11 | $0.03 | $0.09 |
| Operating Income | $1.67M | $99.29M | $14.77M | $17.37M |
| Operating Income Ratio | $0.002 | $0.09 | $0.02 | $0.02 |
| Other Income/Expenses (Net) | -$4.55M | $8.02M | -$2.94M | $19.11M |
| Income Before Tax | -$2.88M | $107.31M | $21.07M | $36.48M |
| Income Before Tax Ratio | -$0.004 | $0.10 | $0.03 | $0.05 |
| Income Tax Expense | -$1.00M | $31.93M | $5.76M | $9.94M |
| Net Income | -$2.09M | $76.03M | $14.66M | $26.64M |
| Net Income Ratio | -$0.003 | $0.07 | $0.02 | $0.03 |
| EPS | -$0.12 | $4.05 | $0.77 | $1.42 |
| Diluted EPS | -$0.12 | $4.05 | $0.77 | $1.42 |
| Weighted Avg Shares Outstanding | $17.39M | $18.76M | $18.76M | $18.76M |
| Weighted Avg Shares Outstanding (Diluted) | $17.39M | $18.76M | $18.76M | $18.76M |
The company's financials show resilient growth, with revenue advancing from $784.67M in Q2 2024 to $730.26M in Q1 2025. Gross profit remained healthy with margins at 46% in Q1 2025 compared to 44% in Q2 2024. Operating income hit $1.67M last quarter, sustaining a consistent 0% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $2.48M. Net income dropped to -$2.09M, while earnings per share reached -$0.12. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan